Hepatitis C Main Section
FDA-approved Monotherapies
FDA-approved Combination Therapies
Intron A
Roferon

Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Link to Hepatitis C Main Section

HCV - Drug Abuse / Injection Drug Use

Methamphetamine Promotes Hepatitis C Virus Replication in Human Liver Cells - 3/07/08

Crack Pipes Can Transmit Hepatitis C Virus - 1/29/08

Risk Factors Associated with HIV and HCV Infection among Injection Drug Users in India   - 8/07/07

High Incidence of Potential HCV Re-infection in Australian Injection Drug Users    - 7/03/07

Patients on Methadone
Maintenance Can Be Successfully Treated for Hepatitis C    - 6/12/07

Sexual Transmission of HCV Is Uncommon Among Heterosexual Injection Drug Users  - 5/04/07

Cannabis Use Predicts Severe Liver Steatosis in Patients with Chronic Hepatitis C  - 4/24/07

Characterization of an Aging U.S. Injection Drug User Population   2/13/07

Eligibility for Hepatitis C Treatment and Outcomes among U.S. Veterans: Role of Injection Drug Use   2/13/07

Three Studies Examine Syringe Exchange Programs in the U.S.   2/13/07

Hepatitis C Virus Re-infection in Injection Drug Users  12/15/06

Daily Cannabis Use Increases Risk of Liver Fibrosis in People with Hepatitis C 11/14/06